Features & Analyses

China proposes landmark Arbitration Law reform, modernizing rules on enforcement of arbitral awards and asset preservation. Hong Kong likely to continue dominating the market for arbitration.

From antitrust to securities laws, being the general counsel of a major real estate brokerage platform requires a generalist skillset

Jerry (Jianwei) Fang and Runyang Liu of Zhong Lun Law Firm introduce China's Personal Information Protection Law and explain a number of vital compliance considerations for multinational corporations

Fang Qi and Danlei Wu of Fangda Partners discuss what information qualifies for trade secrets protection including the scope of trade secrets, protective measures in place for trade secrets and confidentiality of trade secrets with reference to judicial decisions taking a lead role in the development of trade secrets law

Daisy Duan of King & Wood Mallesons discusses enterprises that will qualify to be an applicant under the simplified procedure for unilateral advance pricing arrangements (APAs) and those that are excluded, and the benefits of having a streamlined APA process for MNCs in cross-border transactions

Casper Sek of Jin Mao Partners highlights the requirements of the Regulations on CII Protection from the perspective of compliance practices for companies operating in China and discusses what is a critical information infrastructure and critical information infrastructure operator, the regulators involved and compliance under the new regulations

Hong Kong has played a key role in familiarizing PRC clients with tightening ESG requirements, lawyers say, and it will continue to do so as the city further bolsters rules in this area

Edward Tung, legal counsel for Hong Kong-based venture capital firm ORI Capital, discusses the growing importance of ESG, the rise of special purpose acquisition companies (SPACs) and the advantage of having scientific expertise when representing healthcare and biotechnology companies.

Ting Wu of Haiwen & Partners raises some questions to highlight how China's newly implemented drug patent linkage system attempts to resolve drug patent disputes in the early stages, which will have a sweeping impact on market entry strategies for chemical drugs in China